Simulation study of frontier AI models analyzing 10,000 synthetic Multiple Sclerosis cases reveals variable diagnostic safety
AI Doctors Miss Critical Clues in 10,000 Tests
This simulation study reviewed 10,000 synthetic Multiple Sclerosis cases analyzed by frontier artificial intelligence models against ground-…
Imagine walking into a clinic with a severe headache.
Observational study finds lower delayed recall ratios in multiple sclerosis patients versus controls
Memory fades faster in multiple sclerosis, study finds
This observational study abstract compares memory recall in 127 participants, including 62 multiple sclerosis patients and 65 controls.
People with MS forget more after a week than healthy peers. A simple memory test may spot cognitive decline earlier.
Systematic review and meta-analysis of CBT for depression in multiple sclerosis patients
New NEJM Analysis: CBT Works for MS Depression—No Matter How You Get It
This systematic review and meta-analysis evaluated cognitive behavioral therapy (CBT) for depressive symptoms in patients with multiple scle…
This analysis proves that depression treatment for MS patients can fit their lifestyle, not the other way around.
Narrative review examines resveratrol in Alzheimer's, Parkinson's, MS, and cerebral ischemia with noted limitations
This Common Food Compound May Shield Your Brain From Damage
This narrative review evaluates resveratrol across Alzheimer's disease, Parkinson's disease, multiple sclerosis, and cerebral ischemia.
A natural compound found in berries shows promise for protecting brain cells, but human proof is still missing.
Observational study abstract reports AI RNA sequencing diagnostic accuracy in multiple sclerosis and neuromyelitis optica
Artificial Intelligence identifies early Multiple Sclerosis and separates it from others
This abstract describes an observational diagnostic accuracy study involving 997 participants.
Artificial Intelligence analyzes blood cells to tell early Multiple Sclerosis apart from healthy people and similar conditions like Neuromye…
Higher serum MOG protein levels associated with MS diagnosis and disease activity compared to controls
MS Blood Test Could Reveal Flares Before They Strike
This case-control study examined serum myelin oligodendrocyte glycoprotein (MOG) protein levels in multiple sclerosis (MS) patients versus h…
This study suggests a simple blood test could one day help doctors spot MS flare-ups before they cause damage, offering a new tool to manage…
Switching therapy after rituximab resistance in AQP4-IgG+ NMOSD shows variable relapse outcomes
New Hope for Tough-to-Treat Nerve Disorder
This single-center, retrospective case series of 10 adults with AQP4-IgG+ NMOSD who were resistant to rituximab evaluated switching therapy.
Patients with a rare nerve disease who stopped responding to standard treatment found relief after switching to new therapies that prevented…
Elevated CSF and blood sCD27 associated with autoimmune disease in severe psychiatric disorders and MS
Could a simple protein in spinal fluid reveal hidden autoimmune disease in psychiatric patients?
This cohort study measured soluble CD27 (sCD27) in cerebrospinal fluid and blood from patients with severe psychiatric disorders, multiple s…
A simple spinal fluid protein may reveal hidden autoimmune disease in psychiatric patients who show signs of neuroinflammation.
Narrative review of animal models in neuromyelitis optica spectrum disorder pathogenesis
Animal Models Are Unlocking New Treatments for Rare Brain Disease
This narrative review examines animal models used to study neuromyelitis optica spectrum disorder pathogenesis.
Better animal models are helping scientists understand how NMOSD damages the brain, offering hope for new treatments for patients with few o…
Phase 1b trial of intravenous B001 shows favorable safety in aquaporin-4-positive NMOSD patients
A New MS-Like Disease Drug Passes Its First Human Safety Test
This Phase 1b randomized, double-blind, placebo-controlled trial evaluated intravenous B001 in 22 patients with aquaporin-4 immunoglobulin G…
A new drug for a rare nerve disease that can cause blindness and paralysis passed its first human safety test with no severe side effects se…
Narrative review explores multimodal approaches for autoimmune diseases including rheumatoid arthritis and Crohn's
Scarring From the Inside: How Your Immune System Can Turn Against Your Own Organs
This narrative review examines the integration of immune modulation, epigenetic reprogramming, and mechanobiological interventions for autoi…
Your immune system can cause permanent scarring inside organs like lungs and joints, driving autoimmune diseases such as rheumatoid arthriti…
Oral cladribine reshapes CSF immune cell composition in relapsing multiple sclerosis
Cladribine therapy changes immune cells in fluid from the brain in a small MS study
This single-site phase IV clinical trial used single-cell sequencing on CSF and blood from 13 individuals with relapsing MS before and after…
Cladribine therapy reshapes immune cells in the brain's fluid by reducing harmful memory B cells while boosting protective Treg cells in mul…